Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology AppraisalPharmacoEconomics, 2011-12, Vol.29 (12), p.1051-1062 [Peer Reviewed Journal]Springer International Publishing AG 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591600-000000000-00000 ;PMID: 21967156Full text available |
2 |
Material Type: Article
|
![]() |
Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic ReviewPharmacoEconomics, 2012, Vol.30 (1), p.17-34 [Peer Reviewed Journal]Adis Data Information BV 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11595000-000000000-00000 ;PMID: 22201521Full text available |
3 |
Material Type: Article
|
![]() |
Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of RecurrencePharmacoEconomics, 2011-05, Vol.29 (5), p.415-432 [Peer Reviewed Journal]Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Springer ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588340-000000000-00000 ;PMID: 21504241Full text available |
4 |
Material Type: Article
|
![]() |
Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?PharmacoEconomics, 2010-06, Vol.28 (6), p.463-475 [Peer Reviewed Journal]Adis Data Information BV 2010 ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Jun 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11533000-000000000-00000 ;PMID: 20465315Full text available |
5 |
Material Type: Article
|
![]() |
Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic EvaluationPharmacoEconomics, 2010, Vol.28 (1), p.35-46 [Peer Reviewed Journal]Adis Data Information BV 2010 ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Jan 2010 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11314070-000000000-00000 ;PMID: 20014875Full text available |
6 |
Material Type: Article
|
![]() |
Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses A Decision Tree Model: A Decision Tree ModelPharmacoEconomics, 2010-11, Vol.28 (11), p.1055-1064 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Nov 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11538670-000000000-00000 ;PMID: 20936887Full text available |
7 |
Material Type: Article
|
![]() |
Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular LymphomaPharmacoEconomics, 2012-05, Vol.30 (5), p.413-429 [Peer Reviewed Journal]Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591540-000000000-00000 ;PMID: 22428718Full text available |
8 |
Material Type: Article
|
![]() |
Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug ExpendituresPharmacoEconomics, 2012-01, Vol.30 (7), p.565-573 [Peer Reviewed Journal]Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588320-000000000-00000 ;PMID: 22686661Full text available |
9 |
Material Type: Article
|
![]() |
Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making InternationallyPharmacoEconomics, 2010-01, Vol.28 (5), p.347-349 [Peer Reviewed Journal]Adis Data Information BV 2010 ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11535680-000000000-00000 ;PMID: 20402539Full text available |
10 |
Material Type: Article
|
![]() |
Advances in Cancer Therapeutics and Patient Access to New DrugsPharmacoEconomics, 2011-03, Vol.29 (3), p.213-224 [Peer Reviewed Journal]Springer International Publishing AG 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;COPYRIGHT 2011 Springer ;Copyright Wolters Kluwer Health Adis International Mar 2011 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11584210-000000000-00000 ;PMID: 21184619Full text available |
11 |
Material Type: Article
|
![]() |
Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma: A Systematic ReviewPharmacoEconomics, 2012-07, Vol.30 (7), p.537-549 [Peer Reviewed Journal]Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591160-000000000-00000 ;PMID: 22612993Full text available |
12 |
Material Type: Article
|
![]() |
Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for CancerPharmacoEconomics, 2011-10, Vol.29 (10), p.827-837 [Peer Reviewed Journal]Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11585940-000000000-00000 ;PMID: 21770482Full text available |
13 |
Material Type: Article
|
![]() |
Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic ReviewPharmacoEconomics, 2010-01, Vol.28 (8), p.629-647 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International Aug 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11535560-000000000-00000 ;PMID: 20524722Full text available |
14 |
Material Type: Article
|
![]() |
Economic Burden of Follicular Non-Hodgkin’s LymphomaPharmacoEconomics, 2009-01, Vol.27 (8), p.657-679 [Peer Reviewed Journal]Adis Data Information BV 2009 ;2009 INIST-CNRS ;Copyright Wolters Kluwer Health Adis International Aug 2009 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11314820-000000000-00000 ;PMID: 19712009Full text available |
15 |
Material Type: Article
|
![]() |
Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approachHealth economics, 2008-01, Vol.17 (1), p.67-81 [Peer Reviewed Journal]Copyright © 2007 John Wiley & Sons, Ltd. ;Copyright (c) 2007 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. Jan 2008 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.1243 ;PMID: 17533622 ;CODEN: HEECEZFull text available |
16 |
Material Type: Article
|
![]() |
Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA TrialPharmacoEconomics, 2011-05, Vol.29 (5), p.361-365 [Peer Reviewed Journal]Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11588350-000000000-00000 ;PMID: 21504237Full text available |
17 |
Material Type: Article
|
![]() |
Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast CancerPharmacoEconomics, 2008-01, Vol.26 (8), p.699-719 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826080-00006 ;PMID: 18620462Full text available |
18 |
Material Type: Article
|
![]() |
Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility AnalysisPharmacoEconomics, 2008, Vol.26 (1), p.33-44 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826010-00004 ;PMID: 18088157Full text available |
19 |
Material Type: Article
|
![]() |
The economics of the NHS cancer drugs fundApplied health economics and health policy, 2011-05, Vol.9 (3), p.137-138 [Peer Reviewed Journal]Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2011 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.2165/11585750-000000000-00000 ;PMID: 21506619Full text available |
20 |
Material Type: Article
|
![]() |
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trialApplied health economics and health policy, 2011-09, Vol.9 (5), p.305-315 [Peer Reviewed Journal]Adis Data Information BV 2011 ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International Sep 2011 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.2165/11592200-000000000-00000 ;PMID: 21875161Full text available |